Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 3/2020

01-12-2020 | Cytostatic Therapy | Breast Oncology

Response to: “Letter to the Editor: Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection? Miscalculation of Sensitivity and False Negative Rate”

Authors: Tracy-Ann Moo, MD, Monica Morrow, MD

Published in: Annals of Surgical Oncology | Special Issue 3/2020

Login to get access

Excerpt

We appreciate the time and effort Drs. Smiley and Castaldi have put into analysis of the results reported in our article entitled Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection? Upon review with our statistician, we agree there was an error in the calculation of the false-negative rate and sensitivity for the intraoperative frozen section procedure. As pointed out, the correct false-negative rate for frozen section is 15.4% and the correct sensitivity is 84.6%, instead of the reported 6.2% and 93.8%, respectively. We have submitted a correction to Annals of Surgical Oncology for publication. …
Literature
1.
Rubio IT, Aznar F, Lirola J, Peg V, Xercavins J. Intraoperative assessment of sentinel lymph nodes after neoadjuvant chemotherapy in patients with breast cancer. Ann Surg Oncol. 2010;17(1):235–9.CrossRef
2.
Komenaka IK, Torabi R, Nair G, et al. Intraoperative touch imprint and frozen section analysis of sentinel lymph nodes after neoadjuvant chemotherapy for breast cancer. Ann Surg. 2010;251(2):319–22.CrossRef
Metadata
Title
Response to: “Letter to the Editor: Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection? Miscalculation of Sensitivity and False Negative Rate”
Authors
Tracy-Ann Moo, MD
Monica Morrow, MD
Publication date
01-12-2020
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2020
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-020-08264-5

Other articles of this Special Issue 3/2020

Annals of Surgical Oncology 3/2020 Go to the issue

ASO Author Reflections

ASO Author Reflections: Relationship of Cancer Diagnosis to Complications Following Pancreatoduodenectomy for Duodenal Adenoma: Extreme Force Versus the Right Weapon for the Right Problem

ASO Author Reflections

ASO Author Reflections: Evolving Paradigms in the Treatment of DCIS: Impact of the SSO-ASTRO Margin Guidelines

ASO Author Reflections

ASO Author Reflections: Which Patients with Invasive Intraductal Papillary Mucinous Neoplasm Can Benefit from Adjuvant Therapy?

ASO Author Reflections

ASO Author Reflections: The Theseus Paradox: Marked Lymph Node and Sentinel Lymph Node in pN+ Prechemotherapy Patients: Are They the Same?

ASO Author Reflections

ASO Author Reflections: Which of Smoking Duration or Smoking Intensity Contributes to Poor Prognosis After Resection of Non-small Cell Lung Cancer?

ASO Author Reflections

ASO Author Reflections: Prognostication in Early- and Advanced-Stage Small Bowel Adenocarcinomas